AstraZeneca’s Q4 2024 results underscore strong business momentum, driven by robust revenue growth, key product launches, and significant pipeline advancements. While ongoing compliance issues ...

The board of railway pharma giant AstraZeneca Pharma India has approved ... results for the fourth quarter ended on March 31, 2024, along with a dividend announcement. This is a developing story.

Discover how Cellectis SA (CLLS) is advancing its CAR T therapies and securing financial stability through strategic ...

Discover AstraZeneca's Q1 2025 performance with 10% revenue growth, innovative medicines, and bold 2030 goals.

It is one of the best UK stocks to buy. Overall, 55 hedge funds were bullish on AstraZeneca PLC (NASDAQ:AZN) in Q4 2024, and it was part of 14 billionaire portfolios that had combined stakes worth ...

Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ ... as a surprise was the UK economy going up by 0.1% in Q4 2024, a welcome reprieve from the sodden economic outlook ...